Gastroenterology Flashcards

1
Q

List common differentials for dysphagia & their distinguishing features

A

Oesophageal Ca - WL, anorexia, vomiting during eating. PMHx of barrets/ GORD/ excessive smoking or alcohol use
Oesophagitis - Hx of heartburn. Odynophagia but no weight loss and systemically well
Oesophageal candidiasis - history of HIV or steroid use
Achalasia - dysphagia to both liquids and solids from the start. Heartburn and regurgitation of food. Regurgitation can lead to cough/ aspiration.
Pharyngeal pouch - more common in older men, usually not seen but if so it is a midline lump that gurgles on palpation. Typical sx of dysphagia, regurgitation, aspiration and cough with halitosis.
Systemic sclerosis - Other features of CREST syndrome - Calcinosis, Raynaud’s, Oesophageal dysmotility, sclerodactyly, telangiectasia. As well as oesophageal dysmotility the LES is relaxed - contrasting to achalasia where LES pressure is increased.
Myasthenia gravis - other sx including extraocular muscle weakness or ptosis, dysphagia to both liquids and solids.
Globus hystericus - Hx of anxiety, symptoms are intermitted and relieved by swallowing. Usually painless.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Key differences - Crohns vs UC - Presenting sx

A

Presenting symptoms:

Crohns - non bloody diarrhoae, WL, mouth ulcers, perianal disease.

UC - bloody diarrhoea more common and abdominal pain LLQ + tenesmus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Key differences - Crohns vs UC - Extra intestinal manifestations

A

Crohns - Gallstones are more common in crohns due to reduced bile acid resoprtion.

UC - Primary sclerosing cholangitis more common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is primary sclerosing cholangitis

A

PSC - chronic liver disease characterised by inflammation and fibrosis of the bile ducts leading to cirrhosis and liver failure. Strongly associated with UC but not Crohns. Pathogenesis unclear but thought immune mediated damage to biliary epithelium which can be triggered by gut derived antigens in genetically susceptible individuals. 80% of those with PSC have concurrent UC only 3% associated with crohn’s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Key differences - Crohns vs UC - complications

A

Crohns - Obstruction, fistulas and colorectal cancer

UC - Risk of colorectal cancer is higher in UC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Key differences - Crohns vs UC Pathology

A

Crohns - lesions seen anywhere from mouth to anus and skip lesions.

Histology:
Inflammation in ALL layers from mucosa to serosa.
Increased Goblet cells.
Granulomas Common

UC - Inflammation starts at rectum and never spreads beyond IC valve. Continuous disease.

Histology:
Inflammation from mucosa to lamina propria ( submucosa only).
Neutrophils migrate through the walls of glands to form Crypt Abscesses.
Depletion of Goblet cells and mucin from gland epithelium.
Granulomas rare.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Key differences - Crohns vs UC Endoscopy results

A

Crohns - transmural inflammation and presence of granulomas.
Discontinuous lesions, skip lesions, strictures, linear ulceration.

UC - Mucosal and submucosal inflammation, polymorphonuclear cells aggregate. Continuous lesions, Prescence of crypts, formation of residual mucosal tissue that has the appearance of polyps ( pseudopolyps).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Key differences - Crohns vs UC on radiology

A

Crohns - Small bowel enema has high sensitivity and specificity for terminal ileum. Strictures “ Kantors string sign”. Proximal bowel dilation. “ Rose thorn” ulcers, Fistula.

UC- Barium enema - Loss of haustrations, Superficial ulceration “ pseudopolyps” , colon narrow and short “ Drain pipe colon.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Equation for units of Alcohol

A

Milliliters of drink (mls) x ABV ( percentage strength of drink) / 1000.

E.g. Half standard 175 ml glass of wine - 87.5 x 12/ 1000 = 1.05 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gastric cancer: RF

A

1) Older > 75 yrs
2) male
3) H pylori infection
4) Atrophic gastritis
5) Pernicious anaemia
6) Diet - salt and nitrates
7) Smoking
8) Blood group A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms Gastric cancer

A

Abdominal pain - vague, epigastric, dyspepsia
WL
Anorexia
N & V
Dysphagia - if cancer in proximal stomach
Upper GI bleed ( minority)
Lymphatic spread - L supraclavicular Node ( Virchows node), periumbilical node ( Sister mary joseph nodule).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Investigations and key histological finding in Gastric cancer

A

Endoscopy with biopsy - Signet ring cells ( large vacuole that pushes nucleus to the side). Higher number of signet cells associated with worse prognosis.

Staging CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MX Gastric Ca

A

Surgical - depending on extent and side but include:
Endoscopic mucosal resection
Partial Gastrectomy
Total gastrectomy
Chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SBP - define and pathology

A

SBP - is an infection of the ascitic fluid in patients with Cirrhosis.
Spread of bacteria can be haematogenous from intestines to ascitic fluid. Due to depression of immune function of the liver with cirrhosis, intestinal bacterial overgrowth and venous stasis ( portal HTN) that increases intestinal permeability to enteric bacteria.
Can be non intestinal from RTI/UTI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presentation of SBP

A

Patient with known end stage liver disease ( often decompensated).
Abdominal pain & tender
Ascites - shifting dullness, Flank dullness, fluid wave
Fever
N& V & Diarrhoea ( secondary to intestinal hypomotility and bacterial overgrowth)
Confusion/ hepatic encephalopathy
GI bleed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosis of SBP
MX SBP

A

Paracentesis - neutrophil count > 250 cells/ ul
Most common organism is E Coli

IV cefotaxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When do we give prophylactic abx in SBP?

A

Pts with prev ep SBP
Patients with fluid protein < 15 g/ l or Child pugh score of at least 9 or hepatorenal syndrome

NICE recommend: ‘Offer prophylactic oral ciprofloxacin or norfloxacin for people with cirrhosis and ascites with an ascitic protein of 15 g/litre or less until the ascites has resolved’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DDx of Upper Gi bleed

A

Oesophageal causes:

Oesophagal varices - Large volume of fresh blood. Malaena from swallowed blood. HaemoD compromise. May stop spontaneously but rebleed is common.
Oesophagitis - small volume of fresh blood often streaking vomit, malaena rare. Often stops spont. Hx of GORD.
Cancer - small volume except as preterminal event with erosion of major vessels. Ax sx of dysphagia and WL.
Mallor weiss tear - small to mod volume bright red blood following repeated vomiting. Malaena rare and stops spontaneously.

Gastric causes:
Gastric ulcer - small volume bleed + ida. Erosion into significant vessel may produce considerable haemorrhage / haematemesis.
Gastric Ca - Frank haem or blood mixed w vomit. Usually prodromal sx of dyspepsia and constitutional sx.
Dielaufoy lesion - Often no prodromal features and AVM can produc considerable haemorrhage.
Erosive gastritis - haematemesis & epigastric discomfort. Usually NSAID usage.

Duodenal
Duodenal ulcer - posterior sited and may erode gastroduodenal artery. Pain usually several hours after eating.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Score used for assessment of upper Gi bleed

A

Glasgow Blatchford score - Estimates the risk of Upper GI bleed. Score of 0 suggests consideration of Early D/C.

Takes into account:
Hb count
Urea
SBP
HR
Syncope
Malena
Liver disease
Hf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Scoring used for endoscopy in Upper GI bleed

A

Rockall score = risk of rebleeding and mortality. Takes into account the endoscopy findings plus:
Age
Shock features
Comorbidities
Cause of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

General management tips of Upper GI bleed

A

ABATED:

A-E approach

Bloods &

Access ( two wide bore cannula, FBC, Clotting, G&S , u&Es , LFTs)

Transfusions - Platelets if count < 50, Prothrombin complex concentrate to pts with warfarin. FFP to those with fibrinogen level < 1g/ L or PTT/INR/APTT > 1.5 x normal.

Endoscopy within 24 hours. Should be offered immediately after rescucitation to patients with a severe bleed.

Drugs - stops anticoagulants and NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Management tips for non variceal bleeding

A

NICE do not recommend PPi before endoscopy to pts with suspected non variceal upper GI bleding although PPI should be given to pts with non variceal upper GI bleed & stigmata of recent haemorrhage shown at endoscopy.
Endoscopic mx - thermal cautery, mechanical clips, injection of saline/ adrenaline to induce tamponade with sclerosant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

C Diff infection - pathology

A

Gram +ve rod, produces exotoxin which causes intestinal damage leading to syndrome called pseudomembranous colitis.
C diff develops when normal gut flora are suppressed by broad spectrum abx. 3rd/4th gen cephalosporins - Ceftriaxone/ ceftazadime/ clindamycin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Risk factors for C difficile

A

Broad spectrum abx
increasing age / prolonged hospital stay / nursing home resident
Exposure to infected family member
Hx of prev c diff
IBD
Immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mx of variceal bleeding

A

Terlipressin and prophylactic abx given to pts at presentation ( prior to endoscopy).
Band ligation and injections of sclerosing agents.
TIPS ( transjugular intrahepatic portosystemic shunt) if bleeding not controlled with above measures).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Features of C diff infection

A

Presence of RFs
Diarrhoea
Abdominal pain
Fever
N&V
Abdominal distention / tenderness

*A Raised WCC is characteristic & be aware severe toxic megacolon may develop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Severity scale in C diff infection

A

Mild - normal wcc

Moderate - raised WCC but under 15, 3-5 loose stools/ day

Severe - WCC > 15 or acute creatinine rise > 50% above baseline. T > 38.5 or evidence of severe colitis ( abdominal or radiological signs).

Life threatening - Hypotension, partial or complete ileus, Toxic megacolon or CT evidence of severe disease/

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Diagnosis of C diff infection

A

Detection of C Diff Toxin in stool CDT
C diff antigen positivity only shows exposure to bacteria rather than a current infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Management of C diff infection
Management of recurrent C diff

A

1st line - oral vancomycin 10 d
2nd line - oral fidaxomicin
3rd line - oral vanc +/- IV metronidazole

Life threatening - Oral vancomycin AND IV metronidazole.
Other therapy:
Monoclonal antibody Bezlotoxumab ( NICE not currently supporting).
Faecal microbiota transplant - in those who have had two or more episodes.

Recurrent episode - occurs in 20% of pts, increasing to 50% if 2nd infection. If reccurence before 12 weeks - oral fidaxomicin. After 12 weeks - oral vanc or fidaxomicin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

SE’s of PPi

A

Low Na/ mg
Osteoporosis - increased risk fractures ( malabsorption of mg and Ca)
Microscopic colitis
Increased risk of C diff infection
Can mask symptoms of gastric cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Hepatocellular vs cholestatic vs mixed disease - pattern of ALT/ALP and ALT/ALP ratio

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Metoclopramide SE/Cautions

A

Metoclopramide is a DR receptor antagonist. Has prokinetic actions and is useful in the mx of nausea, diabetic gastroparesis, and in mx of nausea from migraine.

SE:
Exyrapyramidal effects - acute dystonia and oculogyric crisis. Tardive dyskinesis, parkinsonism, hyperprolactinaemia.
Avoid in bowel obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Coeliac disease - 1st line ix

A

First-line investigations for coeliac disease should include a serum immunoglobulin IgA tissue transglutaminase antibody (tTGA) and total IgA. Testing for specific IgA antibodies must be done alongside a total IgA level, as if the patient has an IgA deficiency, the results may be falsely negative. Selective IgA deficiencies are also more common in people with coeliac disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Mx of UC - inducing remission

A

Treating mild - moderate UC :

Proctitis - Rectal aminosalicylate ( mesalazine). If remission not achieved in 4 weeks add oral aminosalicyate. If still not achieved add topical or oral steroid.
Proctosigmoiditis / L sided UC - Topical aminosalicylate. If remission not achieved in 4 weeks switch to high dose oral aminosalicylate and topical steroid. If still not achieved offer oral steroid.
Extensive disease - topical rectal aminosalicylate PLUS oral. IF remission not achieved in 4 weeks stop topical and offer high dose oral + steroid.

Severe UC - Hospital admission, IV steroid 1st line. IV ciclosporin if steroid CI. If after 72 hours unsuccessful then consider adding IV ciclosporin to IV steroid or consider surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

UC mx - maintaining remission

A

Following mild- mod flare of UC:

Proctitis & proctosigmoiditis - Topical rectal aminosalicylate alone OR oral aminosalicylate plus topoical OR oral aminosalicylate alone.
Left sided and extensive UC - Low dose oral aminosalicylate.

Following severe relapse or >= 2 exacerbations / yr then oral azathioprine or oral mercaptopurine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Severities of UC

A

The severity of UC is usually classified as being mild, moderate or severe:
mild: < 4 stools/day, only a small amount of blood
moderate: 4-6 stools/day, varying amounts of blood, no systemic upset
severe: >6 bloody stools per day + features of systemic upset (pyrexia, tachycardia, anaemia, raised inflammatory markers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Mx of variceal haemorrhage

A

A-E - rescucitation, correct clotting and tranfusions ( FFP/Vit K/ platelets)
Terlipressin ( causes vasoconstriction of the splanchnic circulation reducing bleeding)
Prophylactic IV abx - Quinolones

Endoscopy - bang ligation, sclerotherapy, TIPSS if above fails.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Prophylaxis of variceal haemorrhage

A

Propanolol - reduced rebleeding and mortality
Endoscopic band ligation ( superior to sclerotherapy). Performed at two weekly intervals until all varices have been eradicated. PPI cover given to prevent EVL induced ulceration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Guidance on re-testing with H Pylori?

A

NICE guidance advises that we should not routinely offer H. pylori re-testing, however we can consider re-testing if:
There has been poor compliance to eradication therapy
Aspirin or NSAID is indicated
There is a family history of gastric malignancy
The person requests re-testing

They advise that re-testing should ideally be done 8 weeks after initial eradication therapy and the carbon-13 urea breath test should be used first-line.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is Primary biliary cirrhosis?

A

Autoimmune condition with progressive inflammation & damage to the cholangiocytes lining the intrahepatic ducts. Leads to obstruction of bile flow and cholestasis. Ultimately leads to liver fibrosis , cirrhosis and liver failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Presentation of PBC

A

Typically affects females
40- 60 yrs
often asymptomatic on initial presentation then picked up with abnormal LFTs. Bile acids , bilirubin and cholesterol normally excreted via bile ducts build up in the blood. Bile acids cause itching, bilirubin causes jaundice. Lack of bile acids leads to malabsorption of fats and greasy stools, lack of bilirubin excretion leads to pale stools and dark urine. Raised cholesterol leads to deposits in the skin called xanthelasma & xanthomas in skin or tendons ( large cholesterol deposits in tendons). Increased risk CV disease.

Symptoms:
Fatigue
Itching
Abdo pain / RUQ pain
Jaundice
Pale greasy stools
Dark urine

Examination:
Xanthoma and xanthelasma
Excoriation
Hepatomegaly
Signs of liver cirrhosis ( splenomegaly and ascites)
Clubbing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Key investigations in primary biliary cirrhosis

A

LFTs –> ALP raised initially. progressed to full obstructive picture raised bilirubin.

Antibodies :
Antimitochondrial antibodies ( AMA ) m2 - Present in 98% & highly specific
Smooth muscle antibodies in 30% of patients
Raised serum IgM
( ANA also 30% not specific)

Imaging - required before diagnosis to exclude extrahepatic duct biliary obstruction ( RUQ USS or MRCP).

42
Q

Management of primary biliary cirrhosis

A

1st line –> Ursodeoxycholic acid ( slows disease progression and improves symptoms)
( Ursodeoxycholic acid is a hydrophilic bile acid that protects cholagiocytes from inflammation and damage).

Pruritus –> cholestyramine

Immunosuppression - steroids

Fat soluble (DAKE) vitamin supplementation

Liver transplant end stage disease

43
Q

Complications of primary biliary cirrhosis/ cholangitis

A

Liver cirrhosis most importantly
Deficiency DAKE
Osteoporosis
Hyperlipidaemia –> increased CV risk factor

Associated with other AI disease:
Sjogrens
Systemic sclerosis
Thyroid disease
RA

44
Q

2 wk referral criteria for endoscopy in context of dyspepsia - Red flags?

A

Urgent: 2WW for all patients with:

1) Dysphagia
2) upper abdominal mass ( consistent with stomach ca)
3) > 55 yrs with WL & one of: upper abdo pain, reflux or dyspepsia

Non urgent:
1) Haematemesis

Patients > 55 yrs with:
2) treatment resistant dyspepsia
3) upper abdo pain with low Hb
or raised platelet count ( and N/V/WL/Reflux/ dyspepsia/ upper abdominal pain
4) N/V with WL/reflux/dyspepsia/ upper abdo pain

45
Q

NAFLD - stages

Key RFs

A

NAFLD - excessive fats and triglycerides in liver cells that interfere with hepatocyte function.

Stages:
NAFLD ( fat within the liver )
Non alcoholic steatohepatitis ( fat with inflammation)
Fibrosis
Cirrhosis

Risk factors :
Middle age onwards
Obesity
Poor dit / low exercise
T2DM
High cholesterol
HTN
Smoking
Sudden WL and starvation
* Associated with metabolic syndrome which is the triad of HTN, obesity and diabetes. *

46
Q

NAFLD :

Ix

A

IX:
LFT’s - Raised ALT > AST

Increased echogenicity on Liver USS confrim diagnosis of hepatic steatosis ( fat within liver)

ELF ( enhanced liver fibrosis) blood test is 1st line for assess for fibrosis in NAFLD. Measures three markers ( HA PIINP & TIMP-1) and uses algorithm to indicate if there is advanced fibrosis.
> 10.51 or above - advanced fibrosis
under 10.51 - unlikely advanced fibrosis. Recheck 3 yrs.

IF ELF + ve then transient elastography / fibroscan can be used to assess stiffness of the liver using high freq uSS.

If ELF unavailable there are two other scoring systems available - FIB4 score or NAFLD fibrosis score. Both use AST : ALT ratio to assess severity of fibrosis.
Normal ratio less than 1, ratio > 0.8 in NAFLD suggests fibrosis. Used with Fibroscan - good accuracy in fibrosis.

Patients likely to have advanced fibrosis should be referred to liver specialist.
Liver biopsy may be required to confirm diagnosis and is gold standard test.

47
Q

NAFLD - management

A

WL & healthy diet
Exercise
Avoidance EtoH & Smoking
Control of DB / HTN/ High Chol
Referral of those with fibrosis to liver specialist
Specialist management may include medications that sensitive to insuline ( pioglitazone) , bariatric surgery or transplantation.

48
Q

Pancreatic cancer - most common type

Metastases

Presentation

Rf

A

Often diagnosed late and poor prognosis. Vast majority are adenocarcinomas & mostly occur in the head of the pancreas leading to compression of the bile ducts and obstructive jaundice.

Tend to metastasise early especially to the liver, peritoneum, lungs and bones.

Presentation:
Painless, obstructive jaundice * key differential is cholangiocarcinoma*. ( Yellow sclera/skin/ pale stool/ dark urine/ itching & cholestatic LFTs)
Upper abdominal pain or back pain
Unintentional WL
N& V
Anorexia
Palpable masses in epigastric region ( 3rd ) / hepatomegaly (1st)( liver mets) / palpable gallbladder (2nd)
Change in BH
Loss of exocrine function –> steatorrhoea
Loss of endocrine function –> New onset diabetes or worsening of T2DM ** key sign **
Migratory thrombophlebitis ( Trousseau sign)

49
Q

Investigation in pancreatic cancer

A

Bloods:

Deranged LFTs with cholestatic picture
CA 19.9 - tumour marker raised in pancreatic cancer and cholangiocarcinoma.

Imaging:

Abdominal USS
HR CT - Ix of choice if the diagnosis is suspected. May show “ double duct” sign with dilation of common bile and pancreatic duct.
Staging CT TAP - usd to look for metastasis and other cancers.
MRCP to assess biliary system in detail and assess obstruction & ERCP to stent and relieve obstruction.

Special tests:
Biopsy ( percutaneous / USS guided or CT guided or during ERCP)

50
Q

Mx of pancreatic cancer

A

Decided at HPB MDT

Surgical if small tumour isolated in head of pancreas.
Total / distal pancreatectomy OR whipples procedure ( removal of pylorus of stomach, pancreas, duodenum, gall bladder and bileducts & LNs) .
Modified whipples keeps pylorus.
Adjuvant chemotherapy often after surgery.

Most cases curative surgery is not possible. Palliative treatment may involve:
- Stent to relieve obstruction
- Surgery to bypass obstruction
- Palliative chemo or radiotherapy
- EOL care

51
Q

What is Peutz Jeghers syndrome?

A

Peutz Jeghers syndrome is an autosomal dominant condition.

characterised by numerous hamartomatous polyps in the gastrointestinal tract, also associated with pigmented freckles on the lips, face, palms and soles.

polyps themselves don’t have malignant potential, around 50% of patients will have died from another gastrointestinal tract cancer by the age of 60 years.

Features
1) hamartomatous polyps in the gastronintestinal tract (mainly small bowel)
2) small bowel obstruction is a common presenting complaint, often due to intussusception
3) gastrointestinal bleeding
4) pigmented lesions on lips, oral mucosa, face, palms and soles

Management
conservative unless complications develop

52
Q

Key features of Crohns disease ( NESTS)

A

No blood or mucus ( PR bleeding less common)
Entire GI tract ( mouth to anus)
Skip lesions & strictures
Transmural inflammation / terminal ileum most affectd
Smoking risk factor ( do not set nest on fire) ( nSAID/COCP weak evidence of worsening)

53
Q

Medical Management of Crohn’s disease

A

Lifestyle - stop smoking

Inducing remission:
1) Steroids 1st line - oral prednisolone or IV hydrocortisone. Budesonide is an alternative but is less effective.
2) enteral nutrition is an alternative ( particularly if concerns around steroids affecting growth). Enteral nutrition involves specially formulated diet either orally or NG that replaces pts usual diet.
Enteral nutrition induces remission by:
- treating nutritional deficiencies
-Improving gut microbiome
- Removing inflammatory foods
3) Mesalazine ( 5 ASA) -2nd line drug .
4) Azathioprine or mercaptopurine are add on drugs
5) methotrexate alternative to purines in those that cannot tolerate or poor Thiopurinemethyltransferase activity ( TPMT)
5) TNF a i - Infliximab used in refractory disease and fistulating disease. ( Typically continue azathioprine or mercaptopurine) . ( Other TNFa inhibitors adalimumab, ustekinumab, vedolizumab)
6) metronidazole for isolated perianal disease

Maintaining remission:
Azathioprine and mercaptopurine 1st line to maintaining remission

( Methotrexate can be used who cannot tolerate purines or had methotrexate to induce remission)

54
Q

What blood test is required before starting Azathioprine/ mercaptopurine

A

TPMT ( Thiopurine methyltransferase) levels need to be tested before starting pt on azathioprine or mercaptopurine as deficiency can lead to bone marrow suppression.

55
Q

Surgical management of Crohns disease

A

80% of pts with crohns disease will eventually have surgery.

1) Stricturing terminal ileal disease –> ileocaecal resection
2) segmental small bowel resection
3) stricuroplasty

Perianal fistula: Inflammatory tract connection between anal canal and skin.
MRI ix of choice - determine if there is an abscess or fistula is complex ( high fistula passing through all muscle layers) or simple ( low fistula )
- Oral metronidazole for pts with symptomatic fistulas
Anti TNF - infliximab for closing and maintaining closure of perianal fistulas.
Draining seton used for complex fistula ( surgical thread used to keep fistula open and allow drainage, prevent abscess formation).

Perianal abscess - needs I & D + Abx.

56
Q

Complications of Crohn’s disease

A

small bowel cancer (standard incidence ratio = 40)
colorectal cancer (standard incidence ratio = 2, i.e. less than the risk associated with ulcerative colitis)
osteoporosis

57
Q

Drug causes of Hepatocellular liver damage?

A

Paracetamol
Sodium valproate and phenytoin ( AEDs)
MAOI’s ( Antidepressants)
Anti TB drugs ( RIPE)
Statin
Alcohol
Amiodarone
Methyldopa ( antihypertensive)
Nitrofurantoin

58
Q

Drugs causing cholestatic picture of LFTs

A

COCP
Steroids
Abx - co-amoxiclav, flucloxacillin, erythromycin
Antipsychotics - chlorpromazine, prochlorperazine
Sulphonylureas
Fibrates

59
Q

Drugs causing liver cirrhosis

A

MAM
Methotrexate
Amiodarone
Methyldopa ( antihypertensive)

60
Q

haemochromatosis

1) inheritance pattern
2) Genetic problem
3) presentation

A

Haemochromatosis is an Autosomal Recessive disorder. ( require 2x copies to inherit disorder).
Mutations in human haemochromatosis protein ( HFE) gene on chromosome 6, gene important in regulating iron metabolism. ( Encodes for a gene that regulates the expression of iron regulating hormone hepcidin, get low expression of hepcidin therefore uncontrolled duodenal absorption of iron).

Iron accumulates in multiple organs including liver, heart, anterior pituitary, pancreas & joints.

Presentation: * often later presentation in women due to iron loss with menses, typical age > 40 yrs men, later for W *
Chronic tiredness
Joint pain
Pigmentation ( bronze skin)
Anterior pit signs:
Testicular atrophy and erectile dysfunction
Amenorrhoea
Cognitive symptoms - memory and mood disturbance
Hepatomegaly

61
Q

Diagnosis of haemochromatosis

A

1) Serum ferritin is the initial investigation ( marker of total amount of iron in the body)
2) If high need full iron studies - focus on transferrin saturation. Typical iron study profile in patient with haemochromatosis
transferrin saturation > 55% in men or > 50% in women
raised ferritin (e.g. > 500 ug/l) and iron
low TIBC
3) HFE genetic testing
4) LFTs
5) Liver biopsy with PERLs stain ( less common) only if evidence of cirrhosis
5) MRI to quantify liver and cardiac iron

62
Q

Complications of haemochromatosis ?

A

Iron accumulation in multiple organs:

Pituitary - hypogonadism, testicular atrophy, ED, amenorrhoea
Thyroid - hypothyroid
Cardiac - arrythmias and cardiomyopathy
Liver - cirrhosis & hepatocellular carcinoma
Pancreas - T1 DBM
Chondrocalcinosis

63
Q

Mx of haemochromatosis?

A

Venesection - regularly removing blood to remove excess iron ( weekly initially)
Monitoring serum FERRITIN & TRANSFERRIN SATURATION ( ferritin as a measure of total iron stores and transferrin saturation as a measure of how much iron bound to protein in the blood)

64
Q

Oesophageal Cancer:

Most common type
Two types , where are they most common, location in oesophagus and Rf’s?

A

Adenocarcinoma is now the most common type of oesophageal cancer and is more likely to develop in patients with a history of gastro-oesophageal reflux disease (GORD) or Barrett’s.

Key RFs - male, increasing age, smoking & alcohol, barretts , GORD, hiatus hernia , FHX, Low SE status

Non white race - higher risk SCC

65
Q

Presentation of Oesophageal Cancer

A

Dysphagia
Odynophagia ( pain on swallowing)
WL
Anorexia
Vomiting
Hoarseness ( Recurrent LN involvement)
Hiccups ( phrenic nerve)
Cough ( local invasion of tumour to trachea)
Malaena

66
Q

Diagnosis of Oesophageal Ca

A

Upper GI endoscopy with biopsy
Endoscopic USS for local regional staging.
CT CAP - initial staging
PET CT - to detect occult metastases if none found on CT

Treatment:
Operable disease only if T1NOMO - surgical resection with oeosphagectomy or endoscopic therapy ( only superficial low risk lesions).
+ Adjuvant chemotherapy

If not suitable for surgery –> definitive chemoradiotherapy

Palliation if metastatic - palliative chemotherapy & best supportive care

67
Q

Hep B infection:

Ab interpretation

A

Antigens / Antibodies:

Surface antigen HBsAg - active infection. Normally implies acute disease, if present > 6 months then chronic.
Surface antibody (given in vaccination) - HBsAb - implies vaccination, past or current infection.
Core antibodies HBcAb - implies past or current infection. IgM implies acure active infection ( develop 1st 6 mths ) whereas IgG indicates past infection ( develops after 6 mnths) if HBsAg is negative.
E antigen HBeAg - marker of viral replication and high infectivity ( breakdown product of infected liver cells)
HBV DNA - direct count of viral load.

When screening, test HBcAB ( detects prev infection) and HBsAg ( for active infection). If positive need to test HBeAg ( infectivity) and HBV DNA viral load.

68
Q

IBS
What type of disorder is it ?

Key diagnostic features

Triggers?

Red flags?

A

Irritable bowel syndrome is a functional disorder. This means there is no identifiable bowel disease underlying the symptoms, and the symptoms result from the abnormal functioning of an otherwise normal bowel.

Diagnosis of IBS should be considered if patient has the following for at least 6mnths. ABC.

Abdominal pain ( relieved by defecation & worse with eating )
Bloating
Change in bowel habit & stool form ( constipation/ diarrhoea or fluctuating. Stools - loose, watery or hard stools with associated mucus).

A positive diagnosis of IBS should be made if the patient has abdominal pain relieved by defecation or associated with altered bowel frequency stool form, in addition to 2 of the following 4 symptoms:
altered stool passage (straining, urgency, incomplete evacuation)
abdominal bloating (more common in women than men)
symptoms made worse by eating
passage of mucus

Other symptoms - lethargy, nausea, backache and bladder symptoms.
Symptoms may be triggered by
Anxiety/ depression / stress
Sleep disturbance
Illness
Caffiene
Alcohol
Certain foods / medications

Red flags :
Rectal bleeding
WL
FHX ovarian or bowel cancer
Onset > 60 yrs

69
Q

IX in IBS

A

FBC - anaemia
Inflammatory markers - ESR/CRP
Coeliac serology - Anti TTG
Faecal calprotectin for iBD
CA 125 ovarian cancer

70
Q

MX of IBS

A

1) lifestyle - Hydration, regualar small meals, adjustment of fibre intake according to BH ( increase for constip, reduce for diarrhoae), limit caffiene, alcohol & fatty foods.
LOW FODMAP diet
Probiotics
Regular exercise & stress mx

2) Medical:
Loperamide for diarrhoea
Bulk forming laxatives ( isphagula husk) for constipation ( lactulose can cause bloating)
Antispasmodics - mebeverine, alverine, hysocine, peppermint oil)

71
Q

Referral guidelines for suspected pancreatic cancer ?

A

Over 40 yrs with jaundice 2ww
Over 60 yrs with WL plus one additional symptom –> referral for a direct access CT abdomen.

NICE suggest GP referral for direct access CT abdomen ( or USS if not available) to assess for pancreatic cancer if patient has WL plus one of:
Change bowel habit ( D or C)
Back pain
Abdo pain
N or V
* New onset diabetes *

72
Q

Pathophysiology of coeliac disease

Antibodies tested

Endoscopic findings

A

Autoantibodies are created in response to gluten which target epithelial cells of the small intestine leading to inflammation. Inflammation leads to atrophy of intestinal villi and malabsorption.

Antibodies:
tissue transglutaminase (TTG) antibodies (IgA) are first-choice according to NICE
endomyseal antibody (IgA)
needed to look for selective IgA deficiency, which would give a false negative coeliac result
anti-gliadin antibody (IgA or IgG) tests are not recommended by NICE

Endoscopic findings:

Villous atrophy
Crypt hyperplasia
Increase in intraepithelial lymphocytes & invasion into lamina propria

73
Q

Presentation of coeliac disease

A

Often asymptomatic and under diagnosed. Remember to test all new diagnoses of autoimmune thyroid disease and T1DM.

Presentation:
Failure to thrive in children
Diarrhoea
Bloating
Fatigue
WL
Mouth ulcers
dermatitis herpetiformis ( itchy blistering rash on abdomen)
Anaemia can occur scondary to malabsorption leading to neurological symptoms: peripheral neuropathy, ataxia, epilepsy.

74
Q

Diagnosis of coeliac disease

A

Pts must continue to eat gluten for 6 weeks prior to ix.

1st line blood tests —> Total immunoglobulin A levels (to exclude IgA deficiency)
Anti-tissue transglutaminase antibodies (anti-TTG)
Anti-endomysial antibodies (anti-EMA) are a second-line option where there is doubt (e.g., a borderline result).

Patients with a positive antibody test are referred to a gastroenterologist to confirm the diagnosis by endoscopy and jejunal biopsy. Typical biopsy findings are:

Crypt hyperplasia
Villous atrophy

75
Q

Mx of coeliac disease

Complications

A

lifelong gluten-free diet

Complications:
Nutritional deficiency
Anaemia
Osteoporosis
Hyposplenism
Ulcerative jejunitis
Enteropathy-associated T-cell lymphoma (EATL)
Non-Hodgkin lymphoma
Small bowel adenocarcinoma

76
Q

Outline coagulopathy in liver disease

A

In liver failure all clotting factors are low except FVIII which is supra-normal.

FVIII is synthesised in endothelial cells throughout the body and needs hepatocytes to deactivate it. So whilst there is a bleeding risk ( due to deficiency of all other clotting factors ) there is also a risk of venous thrombosis. This is added to by loss of synthesis of natural anticoagulant proteins Protein C & S and antithrombin.

77
Q

What extraintestinal manifestation of Crohns disease correlates to disease activity?

A

Erythema nodosum ( presents as painful red or purple nodules on the shins)

type of panniculitis, or inflammation of the subcutaneous fat, and it is one of the extra-intestinal manifestations of Crohn’s disease that correlates with disease activity.

78
Q

What is primary sclerosing cholangitis?

Risk factors?

A

Primary sclerosing cholangitis - intra and extrahepatic bile ducts become inflamed & damaged developing strictures that obstruct bile flow. Sclerosis - hardening of the ducts and cholangitis - inflammation of ducts.

Chronic bile obstruction eventually leads to liver inflammation, fibrosis and cirrhosis.

RF:
Male
30-40 yrs
Ulcerative colitis ( 80% presenting with PSC have UC, 4% with UC will get PSC)
Crohns
Fhx

79
Q

Presentation of primary sclerosing cholangitis?

Investigation

Risks

A

Often pts asymptomatic at diagnosis with problem picked up on abnormal LFTs.

Male
BG UC
Abdominal pain ruq
Fatigue
Jaundice
Itching
hepatomegaly
Splenomegaly

Investigation:
Deranged LFT - ALP & obstructive picture
Autoantibodies LESS helpful , pANCA +Ve (ANA, Anti SMA )

imaging - MRCP diagnostic - showing bile duct strictures “ beaded appearance”.
Limited role for liver biopsy - fibrous, obliterative changes

Colonoscopy for ? UC

Risks –> increased risk cholangiocarcinoma and colorectal cancer

80
Q

What is pernicious anaemia?

Other causes of this vitamin def?

Pathophysiology

A

Pernicious anaemia is an autoimmune disorder affecting the gastric mucosa that results in vitamin B12 deficiency.

B12 deficiency –> Atrophic gastritis/ H pylori infection, gastrectomy, malnutrtion, alcoholism . Medications that reduce b12 absorption - ppi & Metformin

Pathophysiology:
1) antibodies to intrinsic factor +/- gastric parietal cells
2) intrinsic factor antibodies → bind to intrinsic factor blocking the vitamin B12 binding site
3) gastric parietal cell antibodies → reduced acid production and atrophic gastritis. Reduced intrinsic factor production → reduced vitamin B12 absorption
4) vitamin B12 is important in both the production of blood cells and the myelination of nerves → megaloblastic anaemia and neuropathy

81
Q

RF for pernicious anaemia

A

F: M ( 6:1 )
Middle - older age
Associated AI disorder ( diabetes , thyroid, RA, vitiligo, addisons)
Blood group A

82
Q

Features of pernicious anaemia

A

Anaemia symptoms: SOB, tired, pallor , palpitations, headache.

Glossitis - sore tongue

Neurological –> peripheral neuropathy: ‘pins and needles’, numbness. Typically symmetrical and affects the legs more than the arms.

subacute combined degeneration of the spinal cord: progressive weakness, ataxia and paresthesias that may progress to spasticity and paraplegia

neuropsychiatric features: memory loss, poor concentration, confusion, depression, irritability

83
Q

Investigation in Pernicious anaemia

A

Investigation
1) full blood count
macrocytic anaemia: macrocytosis may be absent in around of 30% of patients
hypersegmented polymorphs on blood film
low WCC and platelets may also be seen

2) vitamin B12 and folate levels
a vitamin B12 level of >= 200 nh/L is generally considered to be normal

3) antibodies
anti intrinsic factor antibodies: sensivity is only 50% but highly specific for pernicious anaemia (95-100%)
anti gastric parietal cell antibodies in 90% but low specificity so often not useful clinically

84
Q

Mx pernicious anaemia

A

Intramuscular hydroxocobalamin is initially given to all patients with B12 deficiency, depending on symptoms:

No neurological symptoms – 3 times weekly for two weeks
Neurological symptoms – alternate days until there is no further improvement in symptoms.

Maintenance depends on the cause:

Pernicious anaemia – 2-3 monthly injections for life
Diet-related – oral cyanocobalamin or twice-yearly injections

85
Q

What should be corrected first, b12 or folate deficiency?

A

When there is B12 & B9 deficiency together, B12 should be corrected first. Giving patient B9 before B12 can lead to subacute combined degeneration of the spinal cord with demyelination of the spinal cord and severe neurological problems.

86
Q

What is achalasia

Presentation

A

Failure of oesophageal peristalsis and of relaxation of the lower oesophageal sphincter (LOS) due to degenerative loss of ganglia from Auerbach’s plexus i.e. LOS contracted, oesophagus above dilated.

Presentation:
Dysphagia to both liquids and solids from the start
Typically variation in severity of symptoms
Heartburn
Regurgitation of food - cough / aspiration
Malignant change in small number of pts

87
Q

Ix and mx of achalasia

A

IX :
Oesophageal manometry - most important diagnostic test, excessive LOS tone.

barium swallow - grossly expanded oesophagus, fluid level, “ birds beak” appearance.

CXR- wide mediastinum and fluid level.

Mx:
Balloon dilatation 1st line
Surgical heller cardiomyotomy if recurrent / persistent sx
Intrasphincteric injection of botulinum toxin
Drug therapy - nitrates , CCB but limited by SE

88
Q

Medication for the prevention of variceal bleeding

MOA?

A

Propanolol - non cardioselective BB used. MOA - reduces Cardiac output and BP, and causes splanchnic vasoconstriction ( by blocking b2 receptors) and reducing portal flow.

89
Q

Wilsons disease - what is it?

A

WD - autosomal recessive disease characterised by excessive copper accumulation in tissues. Mutation in wilson disease protein on Chr 13. (Copper binding protein). Copper binding protein important in removal of excess copper from body via liver. Copper is excreted in bile.

90
Q

Presentation of Wilsons disease?

A

Presenting symptoms result from excessive copper in tissues including the liver, brain and cornea.

Uusally presents in teenager or young adult ( 10-25 yrs) , rarely > 40 yrs. Liver problems usually arise first in children, whereas neurological disease in adults.

Liver –> hepatitis and later cirrhosis

Neurological –>
Tremor & parkinsonism ( rigidity, bradykinesia) due to deposition in basal ganglia.
Dystonia
Speech difficulties

Psychiatric –> abnormal behaviour, depression, cognitive impairment and psychosis.

Kayser Fleischer rings - deposition in cornea.

Haemolytic anaemia
Renal tubular damage

90
Q

Investigation of Wilsons disease?

A

1) Slit lamp examination for kayser fleischer rings

2) Serum caeruloplasmin initial screening test:

LOW caeruloplasmin suggestive of Wilson’s disease & reduced serum copper ( counter intuitive but 95% copper normally bound to caeruloplasmin).
Free Copper is increased.

3) increased 24 hr urinary copper excretion

4) Confirmation with genetic analysis ATP7B gene

91
Q

Mx Wilsons disease

A

Copper chelation either with:
Penicillamine 1st line
Trientine

Other tx:
Zinc salts - inhibit copper absorption in GI tract
Liver transplantation

92
Q

Ascites:

Pathophysiology in liver cirrhosis

A

1) Portal HTN - increase in osmotic pressure pushing fluid into peritoneal cavity
2) Reduced oncotic pressure of the serum due to poor synthetic function of liver ( low albumin states)
3) Activation of RAAS system due to low BP/ Low serum osmolality / redirection of blood flow - increase in Na/H20 retention

93
Q

Ascites causes

A

Grouped into transudative causes or exudative causes based on the serum albumin to ascitic gradient ( SAAG)

SAAG = Serum Albumin - Ascitic fluid albumin
> 11g - transudative
< 11g - exudative

Transudative causes of ascites: ( SAAG > 11g/L)
1) Cirrhosis ( NAFLD/ Alcoholic cirrhosis/ Hep b/c)
2) Acute liver failur
3) liver mets
4) R Heart failure
5) Portal vein thrombosis / Budd chiari ( triad of occlusion of hepatic veins, abdo pain and ascites)

Exudative causes: SAAG < 11g/L
Hypoalbuminaemia - nephrotic syndrome or severe malnutrition
Malignancy - peritoneal mets
Infection - TB peritonitis
Pancreatitis
Biliary ascites
Bowel obstruction
Post op lymph leak

94
Q

Ascitic tap what is sent for?

Other ix in ascites

A

1) appearance :
Clear - liver cirrhosis
Cloudy - SBP / pancreatitis
Bloody - malignancy / haemorrhagic pancreatitis
Milk / chyle - lymhoma, TB or malignancy

2) Biochem:
Protein - high in SBP/TB
Glucose - lower than serum think TB/Malignancy
Amylase ? pancreatitis
RBC - high think TB/ malignancy, very high - trauma.
WBC > 250/uL abnormal, if raised neutrophils - think SBP

3) SAAG ( serum albumin - ascitic albumin gradient)

4) MCS

Other ix:
Bloods - LFT/U&E/FBC/Clotting/ Cultures /CRP / NILS Screen

Abdominal USS
CXR - ? HF/ Pleural effusion

95
Q

Mx of ascites

A

1) Reduce dietary sodium
2) Fluid restriction if Na < 125 mmol
3) Aldosterone antagonists - spironolactone. Can add loop diuretic such as furosemide if above not working.
4) Drainage if tense ascites - therapeutic abdominal paracentesis. Large volume paracentesis requires albumin cover. Removing large vol > 5L can lead to paracentesis induced circulatory dysfunction and hepatorenal syndrome & mortality.
5) Prophylactic Abx in those with Low ascitic protein < 15g then oral ciprofloxacin or norfloxacin until ascites has resolved.
6) TIPS ( transjugular intrahepatic portosystemic shunt) in refractory ascites - Connect portal vein to hepatic vein via a stent bypassing the liver, done in IR under XR guidance.

96
Q

Alcoholic liver disease

Pathophysiology

A

Alcohol metabolised by 1) Alcohol dehydrogenase ( this pathway promotes fatty infiltration of the liver) 2) Cytochrome P450 which increases free radicals and activates hepatic macrophages. Oxidative stress leads to hepatocyte necrosis and apoptosis & increase in free radicals leads to inflammation and fibrosis.

Stages
1) Alcohol releated fatty liver / hepatic steatosis - increase in fat build up in liver, if drinking stops process reverses.
2) Alcoholic hepatitis - inflammation , mild hepatitis reversible with complete abstinence
3) Cirrhosis - irreversible scarring

97
Q

Symptoms of alcoholic liver disease

A

Hx of excess alcohol consumption
Symptoms of liver cirrhosis:
Fatigue
WL
Anorexia
N& V
Jaundice
RUQ pain

Signs:
Smelling of alcohol
Bloodshot eyes
Dilated capillaries on face - telangiectasia
Tremor

Signs of liver cirrhosis:
Jaundice
Hepatomegaly
Splenomegaly
Ascites
Caput medusa
Spider naevi
Gynaecomastia & testicular atrophy
Palmar erythema & Clubbing
Asterixis

98
Q

Investigations of alcoholic liver disease

A

FBC - Raised MCV ( B deficiencies, IDA, GI bleed, hypersplenism)
Reduced platelets ( hyperspenism)

LFTs:
Gamma GT characteristically elevated
AST: ALT ratio > 2, > 3 strongly suggestive alcoholic hepatitis

Raised ALP & bilirubin later in cirrhosis
Low albumin due to reduced synthetic function
Increased prothrombin time - reduced synthetic function clotting factors

U&E’s can be deranged in hepatorenal syndrome

Liver USS - fatty changes and increased echogenicity. Cirrhosis later.
Fibroscan - ? fibrosis

Endoscopy for ? varices

Liver biopsy used to confirm diagnosis of alcohol related cirrhosis , especially in patients where steroids are being considered.

99
Q

Management of alcohol related liver disease?

A

Stop drinking alcohol permanently (drug and alcohol services are available for support)
Psychological interventions (e.g., motivational interviewing or cognitive behavioural therapy)
Consider a detoxication regime
Nutritional support with vitamins (particularly thiamine – vitamin B1) and a high-protein diet
Corticosteroids may be considered to reduce inflammation in severe alcoholic hepatitis to improve short-term outcomes (but not long-term outcomes). Maddreys discriminant function is used , formula basd off prothrombin time and bilirubin. 40 mg prednisilone for 28 days.
Pentoxyphylline also sometimes used. (steroids better evidence) .
Treat complications of cirrhosis (e.g., portal hypertension, varices, ascites and hepatocellular carcinoma)
Liver transplant in severe disease (generally 6 months of abstinence is required)

100
Q

Hepatocellular carcinoma:

Commonest cause
Other causes

Investigation/ screening

A

Chronic hep B is the most common cause worldwide
Chronic hep C is the most common cause in Europe
Other causes/ RFs:
Liver cirrhosis ( alcoholic, NAFLD, )
Alpha 1 antitrypsin
Haemochromatosis
Primary biliary cirrhosis

Diagnosis - Liver USS and alpha fetoprotein performed every 6 months in patients with liver cirrhosis as screening for HCC.
Fibroscans done every 2 yrs in pts at risk of cirrhosis:
1) hep B&C
2) heavy etoh / alcoholic liver disease
3) NAFLD & ELF blood test indicating fibrosis

101
Q

What is hepatorenal syndrome

A

Hypertension in the portal system leads to vessel dilation and reduced vascular resistance. This lads to under filtration of the kidneys. Under filtration activates the RAAS causing vasoconstriction , which combined with a low circulating volume leads to further underfiltration of the kidneys and rapid deterioration in renal function.

102
Q
A